Subtle Medical Raises Nearly $10M in Series B+ Round

Subtle Medical Raises Nearly $10M in Series B+ Round

Subtle Medical, a Menlo Park, CA-based AI-powered medical image acquisition, has raised of nearly $10 million in Series B+ funding.

The round includes participation from existing shareholders like Fusion Fund and prominent global investors, such as EnvisionX Capital, BRV Capital, Ignite Innovation, and Samsung Ventures. With this latest infusion, Subtle Medical's Series B funding now exceeds $30 million, bringing the total financing to over $50 million.

The company will use the funding to support accelerated US and global sales initiatives and to expedite the launch of new AI-driven products.

Founded in 2017 by Dr. Enhao Gong and Dr. Greg Zaharchuk, Subtle Medical is a medical imaging software company that leverages AI and advanced generative models to enhance the data acquisition stage of medical imaging exams, including MRI, PET, CT, SPECT, and angiography. The company's cutting-edge solutions optimize imaging workflows and improve productivity and patient experience. Headquartered in Silicon Valley with a globally distributed team, Subtle Medical primarily offers AI solutions as SaaS or software systems to hospitals and imaging centers in the United States, Europe, and Latin America.

Funding Details

Company: Subtle Medical, Inc.

Raised: $10.0M

Round: Series B+

Funding Month: July 2024

Investors: Fusion Fund, EnvisionX Capital, BRV Capital, Ignite Innovation, Samsung Ventures

Company Website: https://subtlemedical.com/

Software Category: Medical Imaging